You are here

Substance Abuse

Displaying 1 - 10 of 17, sorted by most recent
Contains
Contains
Format: 2024
Greater than or equal to
James A. Chance, Evan Lee, Laurie Levenson
October 28, 2021

Federal Criminal Statutes. Experts discuss the Court’s refusal to read statutes broadly and the importance of judges considering the impacts of race and addiction in sentencing. 

Joseph LaFratta, Mary Page Kelley, Jason A. Cantone
December 3, 2020

Chief Magistrate Judge M. Page Kelley (D. Mass.) and Deputy Chief Probation Officer Joseph LaFratta (D. Mass.) discuss the structure, commitment required, and lessons learned from their court’s experience with a successful drug treatment court program. 

 

Kelly Dunn, Jason A. Cantone
December 3, 2020

Dr. Kelly Dunn, from the Johns Hopkins University School of Medicine, explains how psychologists treat individuals with opioid use disorder and chronic pain, which includes techniques such as cognitive behavioral therapy (CBT).

Loretta Rush
December 3, 2020

Chief Justice Loretta Rush (Indiana Supreme Court) shares her experience as a chair of the National Judicial Opioid Task Force, presenting the findings of the task force as well as new resources and a call for enhanced cooperation between federal and state courts in addressing the opioid crisis. 

Ricardo S. Martinez
December 3, 2020

In this module, Chief Judge Ricardo Martinez (W.D. Wash.) relates lessons from his extensive experience running drug court programs in both state and federal courts.

Louis F. Ortenzio Jr., Hanna Umanskiy Ortiz
December 3, 2020

Lou Ortenzio, a former physician who lost his career and his marriage in his struggle with opioids, shares his experience assisting others who seek to recover from substance use disorder in his home town of Clarksburg, West Virginia.

Irene M. Keeley
December 3, 2020

In concluding remarks, Judge Irene Keeley (N.D. W.

Christopher Jones, Hanna Umanskiy Ortiz
December 3, 2020

Dr. Christopher Jones, U.S. Public Health Service and Centers for Disease Control and Prevention (CDC), reviews current options (to include methadone, buprenorphine and naltrexone) in Medication-Assisted Treatment (MAT) for those with an opioid use disorder.

Wilson Compton, Jason A. Cantone
December 3, 2020

Dr. Wilson Compton, deputy director of the National Institute on Drug Abuse (NIDA), explains what judges need to know about the biology, neurobiology, and chemistry of opioid use disorder.

Pages

Subscribe to Substance Abuse